Concierge MedTravel Bridges the Gap for Treatment of Prostate Cancer
Hauppauge, NY, October 24, 2008 --(PR.com)-- Concierge MedTravel, website www.cmedtravel.com, a company bridging the gap for patients diagnosed with prostate cancer with highly advanced medical treatment called Ablatherm® HIFU currently not available in the United States, achieved an important milestone since the inception of Concierge MedTravel. Their first two clients, flown from Idaho and Ohio to The University of Regensburg, St. Josef Hospital, Regensburg, Germany, one of the most advanced medical centers in the world specializing in urology and novel prostate cancer treatments, received a PSA scores of 0.05, and 0.14, approximately 3 months after their Ablatherm® HIFU treatments.
Ablatherm® HIFU an innovative technology developed by EDAP TMS S.A. the global leader in High Intensity Focused Ultrasound (HIFU) for the treatment of prostate cancer, uses High Intensity Focused Ultrasound waves with extreme precision to effectively destroy targeted cancer cells. Ablatherm® HIFU is a minimally invasive treatment option with a low occurrence of side effects.
Today in the United States, Obstetric Gynecologists and Urologists use lower amounts of energy, ultrasound waves routinely to image an unborn child in a mother’s womb or to dissolve kidney stones.
Concierge MedTravel’s client Mr. C is 65 years old and lives in Idaho. In 2007, Mr. C had a PSA level of 3.9. In May 2008, PSA elevated to 5.2. On May 29, 2008, prostate cancer was confirmed by a biopsy, Gleason Score 7 (3+4), cancer on left side of prostate in 6 of 9 cores with a prostate size at 37 cc. Mr. C researched his options and on June 23, 2008, Mr. C signed agreement with Concierge MedTravel. On July 15, Mr. C received Ablatherm® HIFU treatment at The University of Regensburg, St. Josef Hospital, Regensburg, Germany. On September 8, Mr. C had a follow up PSA test. On September 14, 2008 Mr. C received the results—a PSA level of 0.05.
“Last month, I spoke with Mr. C and his wife and they are absolutely thrilled with the news of Mr. C’s PSA score. We are very pleased that we can help American men cure their prostate cancer” states Broughan Gorey, CEO of Concierge MedTravel. “Ablatherm® HIFU is the most advanced and clinically proven choice of HIFU treatment for patients with localized prostate cancer or who have failed radiation therapy.”
###
Contact:
Elaine De Luca Byrnes
631-366-2705
edbyrnes@lucecreative.com
Ablatherm® HIFU an innovative technology developed by EDAP TMS S.A. the global leader in High Intensity Focused Ultrasound (HIFU) for the treatment of prostate cancer, uses High Intensity Focused Ultrasound waves with extreme precision to effectively destroy targeted cancer cells. Ablatherm® HIFU is a minimally invasive treatment option with a low occurrence of side effects.
Today in the United States, Obstetric Gynecologists and Urologists use lower amounts of energy, ultrasound waves routinely to image an unborn child in a mother’s womb or to dissolve kidney stones.
Concierge MedTravel’s client Mr. C is 65 years old and lives in Idaho. In 2007, Mr. C had a PSA level of 3.9. In May 2008, PSA elevated to 5.2. On May 29, 2008, prostate cancer was confirmed by a biopsy, Gleason Score 7 (3+4), cancer on left side of prostate in 6 of 9 cores with a prostate size at 37 cc. Mr. C researched his options and on June 23, 2008, Mr. C signed agreement with Concierge MedTravel. On July 15, Mr. C received Ablatherm® HIFU treatment at The University of Regensburg, St. Josef Hospital, Regensburg, Germany. On September 8, Mr. C had a follow up PSA test. On September 14, 2008 Mr. C received the results—a PSA level of 0.05.
“Last month, I spoke with Mr. C and his wife and they are absolutely thrilled with the news of Mr. C’s PSA score. We are very pleased that we can help American men cure their prostate cancer” states Broughan Gorey, CEO of Concierge MedTravel. “Ablatherm® HIFU is the most advanced and clinically proven choice of HIFU treatment for patients with localized prostate cancer or who have failed radiation therapy.”
###
Contact:
Elaine De Luca Byrnes
631-366-2705
edbyrnes@lucecreative.com
Contact
Concierge MedTravel
Elaine De Luca Byrnes
631-366-2705
www.cmedtravel.com
Elaine De Luca Byrnes
631-366-2705
www.cmedtravel.com
Contact
Categories